Tarkoititko:
drug endoderm » during endoderm (Laajenna hakua), drive endoderm (Laajenna hakua), gut endoderm (Laajenna hakua)
drugs does » drugs do (Laajenna hakua)
does devel » does level (Laajenna hakua), does deep (Laajenna hakua), does novel (Laajenna hakua)
devel ther » novel ther (Laajenna hakua), level theory (Laajenna hakua), develop them (Laajenna hakua)
drug endoderm » during endoderm (Laajenna hakua), drive endoderm (Laajenna hakua), gut endoderm (Laajenna hakua)
drugs does » drugs do (Laajenna hakua)
does devel » does level (Laajenna hakua), does deep (Laajenna hakua), does novel (Laajenna hakua)
devel ther » novel ther (Laajenna hakua), level theory (Laajenna hakua), develop them (Laajenna hakua)
1
“... are constantly under pressure, higher percentages of drugs are demanded, and the drug-discovery process is a...”
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
2
3
Tekijä Kim, Choon Ok, Oh, Eun Sil, Kim, Hohyun, Park, Min Soo
Julkaisussa Drug Des Devel Ther (2017)
“..., this study aimed to evaluate the pharmacokinetic (PK) interactions between these two drugs in healthy males...”Julkaisussa Drug Des Devel Ther (2017)
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
4
Tekijä Guerrero-Orriach, Jose Luis, Escalona Belmonte, Juan Jose, Ramirez Fernandez, Alicia, Ramirez Aliaga, Marta, Rubio Navarro, Manuel, Cruz Mañas, Jose
Julkaisussa Drug Des Devel Ther (2017)
“... of the administered drug and the duration of the administration itself. Triggers for postconditioning...”Julkaisussa Drug Des Devel Ther (2017)
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
5
6
Tekijä Gahr, Maximilian, Kölle, Markus A, Schönfeldt-Lecuona, Carlos, Lepping, Peter, Freudenmann, Roland W
Julkaistu 2011
“... pharmacological profile, including single dosing, predominantly renal excretion, low drug–drug interaction risk...”Julkaistu 2011
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
7
Tekijä Celik Kavak, Ebru, Gulcu Bulmus, Funda, Bulmus, Ozgur, Kavak, Salih Burcin, Kocaman, Nevin
Julkaisussa Drug Des Devel Ther (2018)
“... 2, bilateral ovarian torsion; Group 3, bilateral ovarian torsion–detorsion; Group 4, MgSO(4)–sham...”Julkaisussa Drug Des Devel Ther (2018)
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
8
9
Tekijä Erkılıç, E, Kesimci, E, Alaybeyoğlu, F, Kılınç, I, Tural, R, Yazgan, A, Gümüş, T, Sepici Dinçel, A, Dumlu, EG, Kanbak, O
Julkaisussa Drug Des Devel Ther (2017)
“... after reperfusion, and 6 hours after the surgical procedure (T0, T1, T2, and T3, respectively). RESULTS...”Julkaisussa Drug Des Devel Ther (2017)
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
10
11
Tekijä Xiao, Jing, Wan, Wenbo, Zhang, Ying, Ma, Jun, Yan, Lin, Luo, Yukun, Tang, Jie
Julkaisussa Drug Des Devel Ther (2021)
“... randomly divided into three groups (n = 8/group): the control group (saline-infused rabbits without IRI...”Julkaisussa Drug Des Devel Ther (2021)
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
12
“... therapies. Kinases are one of the most common drug targets with a potential for cancer therapy. Cell cycle...”
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
13
“... in the three groups. The initial infusion rate of first patient was 0.5 µg/kg/min. Then, the rate for next...”
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
14
Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients...
Tekijä Cho, Eun Ju, Yu, Su Jong, Kwon, So Young, Kim, Ji-Hoon, Kim, Do Young, Kim, Won, Lee, June Sung, Lee, Jin Woo, Lee, Youn Jae, Chae, Hee Bok, Yoon, Jung-Hwan
Julkaisussa Drug Des Devel Ther (2018)
“... by 26.4% and 9.3%, respectively, in the fed group compared with the fasted group. However, the differences...”Julkaisussa Drug Des Devel Ther (2018)
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
15
“... potential drug target in lung cancer. However, CDH1 methylation does not correlate with other factors...”
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
16
Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action
Tekijä Vonderlin, Nadine, Fischer, Fathima, Zitron, Edgar, Seyler, Claudia, Scherer, Daniel, Thomas, Dierk, Katus, Hugo A, Scholz, Eberhard P
Julkaisussa Drug Des Devel Ther (2015)
“... trafficking, we further found that midazolam does not affect channel surface expression. Taken together, we...”Julkaisussa Drug Des Devel Ther (2015)
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
17
Tekijä Tsagogiorgas, Charalambos, Anger, Friedrich, Beck, Grietje, Breedijk, Annette, Yard, Benito, Hoeger, Simone
Julkaisussa Drug Des Devel Ther (2019)
“...H8-cEM and their drug delivery properties. Afterward, an in vivo study was performed as a proof...”Julkaisussa Drug Des Devel Ther (2019)
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
18
Tekijä Hu, Fei, Miao, Lin, Zhao, Yu, Xiao, Yuan-Yuan, Xu, Qing
Julkaisussa Drug Des Devel Ther (2015)
“...) The expression levels of CXCR4 does not increase during local progression, however, CXCR4 expression increases...”Julkaisussa Drug Des Devel Ther (2015)
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
19
N-(3-hydroxymethyl-β-carboline-1-yl-ethyl- 2-yl)-l-Phe: development toward a nanoscaled antitumor...
Tekijä Wu, Jianhui, Zhao, Ming, Wang, Yuji, Wang, Yaonan, Zhu, Haimei, Zhao, Shurui, Gui, Lin, Zhang, Xiaoyi, Peng, Shiqi
Julkaisussa Drug Des Devel Ther (2017)
“... are rich in P-selectin. N-(3-hydroxymethyl-β-carboline-1-yl-ethyl-2-yl)-l-Phe (HMCEF) is a P-selectin...”Julkaisussa Drug Des Devel Ther (2017)
Hae kokoteksti
Hae kokoteksti
Hae kokoteksti
Artigo
20